$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Bluetongue vaccines

Vaccine, v.27 suppl.4, 2009년, pp.D86 - D89  

Noad, R. (Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, United Kingdom) ,  Roy, P.

Abstract AI-Helper 아이콘AI-Helper

Once thought largely restricted to India and Africa, the insect-borne livestock pathogen Bluetongue virus is now present on every continent with the exception of Antarctica. Outbreaks of the disease caused by the virus in Europe over the last decade, and the resulting impact on trade and agriculture...

주제어

참고문헌 (32)

  1. Prev Vet Med Mellor 87 October (1-2) 4 2008 10.1016/j.prevetmed.2008.06.002 Bluetongue in Europe and the Mediterranean Basin: history of occurrence prior to 2006 

  2. Clin Infect Dis Gubler 45 October (8) 1039 2007 10.1086/521911 The continuing spread of West Nile virus in the western hemisphere 

  3. Adv Virus Res Vasilakis 72 1 2008 10.1016/S0065-3527(08)00401-6 The history and evolution of human dengue emergence 

  4. Prev Vet Med Elbers 87 October (1-2) 31 2008 10.1016/j.prevetmed.2008.06.003 Field observations during the Bluetongue serotype 8 epidemic in 2006. II. Morbidity and mortality rate, case fatality and clinical recovery in sheep and cattle in the Netherlands 

  5. Transbound Emerg Dis Vercauteren 55 September (7) 293 2008 10.1111/j.1865-1682.2008.01034.x Bluetongue virus serotype 8-associated congenital hydranencephaly in calves 

  6. Prog Clin Biol Res Huismans 178 347 1985 Immune response against the purified serotype specific antigen of bluetongue virus and initial attempts to clone the gene that codes for the synthesis of this protein 

  7. Onderstepoort J Vet Sci Anim Ind Alexander 25 3 1951 The use of egg attenuated bluetongue virus in the production of a polyvalent vaccine for sheep: a propagation of the virus in sheep 

  8. Vet Rec Parker 96 March (13) 284 1975 10.1136/vr.96.13.284 An experimental inactivated vaccine against bluetongue 

  9. Vaccine Campbell 3 December (5) 401 1985 10.1016/0264-410X(85)90131-8 Immunogenicity of bluetongue virus inactivated by gamma irradiation 

  10. Onderstepoort J Vet Res Hunter 68 December (4) 331 2001 A monovalent attenuated serotype 2 bluetongue virus vaccine confers homologous protection in sheep 

  11. Am J Vet Res Lacetera 65 October (10) 1331 2004 10.2460/ajvr.2004.65.1331 Evaluation of antibody response and nonspecific lymphocyte blastogenesis following inoculation of a live attenuated bluetongue virus vaccine in goats 

  12. Comp Immunol Microbiol Infect Dis Savini 31 March (2-3) 101 2008 10.1016/j.cimid.2007.07.006 Vaccines against bluetongue in Europe 

  13. Nat Rev Microbiol Roy 7 February (2) 120 2009 10.1038/nrmicro2052 Prospects for improved bluetongue vaccines 

  14. Vaccine Roy 12 July (9) 805 1994 10.1016/0264-410X(94)90289-5 Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection 

  15. J Virol Roy 64 May (5) 1998 1990 10.1128/JVI.64.5.1998-2003.1990 Recombinant virus vaccine for bluetongue disease in sheep 

  16. Virology Loudon 182 June (2) 793 1991 10.1016/0042-6822(91)90620-Q Expression of the outer capsid protein VP5 of two bluetongue viruses, and synthesis of chimeric double-shelled virus-like particles using combinations of recombinant baculoviruses 

  17. Vaccine Roy 10 1 28 1992 10.1016/0264-410X(92)90415-G Protective efficacy of virus-like particles for bluetongue disease 

  18. Methods Xiang 40 September (1) 1 2006 10.1016/j.ymeth.2006.05.016 Pathogen recognition and development of particulate vaccines: does size matter? 

  19. Int J Med Microbiol Nassal 298 January (1-2) 135 2008 10.1016/j.ijmm.2007.08.002 Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: new particulate Lyme disease vaccines 

  20. Vet Immunol Immunopathol Lobato 59 November (3-4) 293 1997 10.1016/S0165-2427(97)00084-6 Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens 

  21. Vaccine Boone 25 January (4) 672 2007 10.1016/j.vaccine.2006.08.025 Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep 

  22. Virology Wade-Evans 220 June (1) 227 1996 10.1006/viro.1996.0306 Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge 

  23. Vet Ther Siger 7 Fall (3) 249 2006 Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses 

  24. Arch Virol Minke 18 Suppl 221 2004 Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge 

  25. Am J Vet Res Minke 68 February (2) 213 2007 10.2460/ajvr.68.2.213 Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge 

  26. Vet Rec Poulet 153 August (5) 141 2003 10.1136/vr.153.5.141 Efficacy of a canarypox virus-vectored vaccine against feline leukaemia 

  27. Curr Opin Mol Ther Rees 4 February (1) 49 2002 Disabled infectious single cycle-herpes simplex virus (DISC-HSV) as a vector for immunogene therapy of cancer 

  28. Vaccine Schleiss 24 September (37-39) 6175 2006 10.1016/j.vaccine.2006.06.077 Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine 

  29. J Virol Boyce 81 March (5) 2179 2007 10.1128/JVI.01819-06 Recovery of infectious bluetongue virus from RNA 

  30. J Virol Boyce 82 September (17) 8339 2008 10.1128/JVI.00808-08 Development of reverse genetics systems for bluetongue virus: recovery of infectious virus from synthetic RNA transcripts 

  31. J Virol Matsuo 2009 10.1128/JVI.00465-09 Bluetongue virus VP6 acts early in the replication cycle and can form the basis of chimaeric virus formation 

  32. J Virol Celma 83 July (13) 6806 2009 10.1128/JVI.00263-09 A viral nonstructural protein regulates bluetongue virus trafficking and release 

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로